Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ATRA)

CUSIP: 046513107

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 7 signals
Share change
-12,049,015
Put/Call ratio
2.1%
SEC-reported price per share
$1.61
Number of holders
115
Value change
-$23,260,244
Number of buys
57
Open additional details 1 more signal available
Number of sells
70
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
9,606,000

Security key

046513107

Report period

Q2 2023

Institutions

115

Top holders

10

Ownership snapshot

Top reported holders of ATRA - Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
31 Mar 2023
13F Highest disclosed value: $26,886,765 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $26.89M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value Top 5
BlackRock Finance, Inc. $26.89M
BAUPOST GROUP LLC/MA $26.46M
WASATCH ADVISORS LP $24.23M
STATE STREET CORP $23.89M
JPMORGAN CHASE & CO $22.2M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$26,886,765
9,271,298 shares
— 31 Mar 2023
BAUPOST GROUP LLC/MA
13F
Company
13F
—
denominator unverified
$26,458,000
9,123,616 shares
— 31 Mar 2023
WASATCH ADVISORS LP
13F
Company
13F
—
denominator unverified
$24,227,531
8,354,321 shares
— 31 Mar 2023
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$23,888,672
8,237,473 shares
— 31 Mar 2023
JPMORGAN CHASE & CO
13F
Company
13F
—
denominator unverified
$22,201,000
7,655,769 shares
— 31 Mar 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$19,880,040
6,855,186 shares
— 31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
115
Shares
90,354,566
Rows available
115
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2026 Across Filers

Q1 2026 holders
1
Q2 2023 holders
115
Holder diff
114
Investor Q1 2026 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2026 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .